Peripheral Perfusion and Outcomes in ICU Patients With Sepsis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAlexandra Elena Lazăr
About this trial
People with sepsis who are treated in the intensive care unit (ICU) often have impaired blood flow to the skin and other tissues. These alterations in tissue perfusion may be associated with disease severity and clinical outcomes.
The aim of this study is to see whether simple signs of blood flow to the skin, such as capillary refill time and blood test measurements, are linked to outcomes in people with sepsis treated in the ICU.
Adults with sepsis who are admitted to the ICU will be invited to take part. Researchers will collect routine clinical data and blood test results during the first day of ICU treatment. No extra procedures or treatments will be performed as part of the study.
The results of this study may improve understanding of early signs of impaired circulation in sepsis and their relation with recovery and survival.
Eligibility criteria
Qualifiers
adults aged 18 years or older
admission to the intensive care unit
sepsis or septic shock, defined according to Sepsis-3 criteria
SOFA score ≥ 2 at inclusion
Disqualifiers
age under 18 years
pregnancy
expected ICU stay less than 24 hours
limitations of therapy at ICU admission (e.g., DNR or comfort-only care)
Trial design
Treatments tested in this trial
- PERIPHERAL PERFUSION EVALUATION
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Alexandra Elena Lazăr
Lead sponsor
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Sponsor institution
Source ClinicalTrials.gov